Cognitive therapy to prevent depressive relapse in adults

Jeffrey R. Vittengl, Robin B. Jarrett

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.

Original languageEnglish (US)
Pages (from-to)26-31
Number of pages6
JournalCurrent Opinion in Psychology
Volume4
DOIs
StatePublished - Aug 1 2015

Fingerprint

Cognitive Therapy
Recurrence
Depression
Maintenance
Drug Therapy
Acute-Phase Reaction
Major Depressive Disorder
Costs and Cost Analysis
Wounds and Injuries

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Cognitive therapy to prevent depressive relapse in adults. / Vittengl, Jeffrey R.; Jarrett, Robin B.

In: Current Opinion in Psychology, Vol. 4, 01.08.2015, p. 26-31.

Research output: Contribution to journalArticle

@article{3f9f0b1d489a46aa9e5edd0bae1285cf,
title = "Cognitive therapy to prevent depressive relapse in adults",
abstract = "The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.",
author = "Vittengl, {Jeffrey R.} and Jarrett, {Robin B.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.copsyc.2015.01.016",
language = "English (US)",
volume = "4",
pages = "26--31",
journal = "Current Opinion in Psychology",
issn = "2352-250X",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Cognitive therapy to prevent depressive relapse in adults

AU - Vittengl, Jeffrey R.

AU - Jarrett, Robin B.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.

AB - The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.

UR - http://www.scopus.com/inward/record.url?scp=84923348267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923348267&partnerID=8YFLogxK

U2 - 10.1016/j.copsyc.2015.01.016

DO - 10.1016/j.copsyc.2015.01.016

M3 - Article

C2 - 25729758

AN - SCOPUS:84923348267

VL - 4

SP - 26

EP - 31

JO - Current Opinion in Psychology

JF - Current Opinion in Psychology

SN - 2352-250X

ER -